A citation-based method for searching scientific literature

Christine Pirker, Agnes Bilecz, Michael Grusch, Thomas Mohr, Barbara Heidenreich, Viktoria Laszlo, Paul Stockhammer, Daniela Lötsch-Gojo, Johannes Gojo, Lisa Gabler, Sabine Spiegl-Kreinecker, Balazs Dome, Ariane Steindl, Thomas Klikovits, Mir Alireza Hoda, Marko Jakopovic, Miroslav Samarzija, Katja Mohorcic, Izidor Kern, Barbara Kiesel, Luka Brcic, Felicitas Oberndorfer, Leonhard Müllauer, Walter Klepetko, Wolfgang M Schmidt, Rajiv Kumar, Balazs Hegedus, Walter Berger. Clin Cancer Res 2020
Times Cited: 5







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression.
Daniel Rathkey, Manakamana Khanal, Junko Murai, Jingli Zhang, Manjistha Sengupta, Qun Jiang, Betsy Morrow, Christine N Evans, Raj Chari, Patricia Fetsch,[...]. J Thorac Oncol 2020
17
40

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
Gérard Zalcman, Julien Mazieres, Jacques Margery, Laurent Greillier, Clarisse Audigier-Valette, Denis Moro-Sibilot, Olivier Molinier, Romain Corre, Isabelle Monnet, Valérie Gounant,[...]. Lancet 2016
411
40

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival.
Lisa Quetel, Clément Meiller, Jean-Baptiste Assié, Yuna Blum, Sandrine Imbeaud, François Montagne, Robin Tranchant, Julien de Wolf, Stefano Caruso, Marie-Christine Copin,[...]. Mol Oncol 2020
19
40

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.
Raphael Bueno, Eric W Stawiski, Leonard D Goldstein, Steffen Durinck, Assunta De Rienzo, Zora Modrusan, Florian Gnad, Thong T Nguyen, Bijay S Jaiswal, Lucian R Chirieac,[...]. Nat Genet 2016
382
40

Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.
Lee M Krug, Hedy L Kindler, Hilary Calvert, Christian Manegold, Anne S Tsao, Dean Fennell, Ronny Öhman, Ruth Plummer, Wilfried E E Eberhardt, Kazuya Fukuoka,[...]. Lancet Oncol 2015
106
40

Integrative Molecular Characterization of Malignant Pleural Mesothelioma.
Julija Hmeljak, Francisco Sanchez-Vega, Katherine A Hoadley, Juliann Shih, Chip Stewart, David Heiman, Patrick Tarpey, Ludmila Danilova, Esther Drill, Ewan A Gibb,[...]. Cancer Discov 2018
185
40

Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
Simonetta Guarrera, Clara Viberti, Giovanni Cugliari, Alessandra Allione, Elisabetta Casalone, Marta Betti, Daniela Ferrante, Anna Aspesi, Caterina Casadio, Federica Grosso,[...]. J Thorac Oncol 2019
15
40

Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
Marta Betti, Anna Aspesi, Daniela Ferrante, Marika Sculco, Luisella Righi, Dario Mirabelli, Francesca Napoli, Milena Rondón-Lagos, Elisabetta Casalone, Francesca Vignolo Lutati,[...]. Genes Chromosomes Cancer 2018
20
40

Prognostic value of the lymphocyte-to-monocyte ratio and other inflammatory markers in malignant pleural mesothelioma.
Abdullah Cetin Tanrikulu, Abdurrahman Abakay, Halil Komek, Ozlem Abakay. Environ Health Prev Med 2016
13
40

Identification of novel markers for the diagnosis of malignant pleural mesothelioma.
Fabien Gueugnon, Sabrina Leclercq, Christophe Blanquart, Christine Sagan, Laurent Cellerin, Martine Padieu, Christian Perigaud, Arnaud Scherpereel, Marc Gregoire. Am J Pathol 2011
58
40

A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition.
Steven R Whittaker, Jean-Philippe Theurillat, Eliezer Van Allen, Nikhil Wagle, Jessica Hsiao, Glenn S Cowley, Dirk Schadendorf, David E Root, Levi A Garraway. Cancer Discov 2013
225
20

Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.
Wei Li, Jonathan Cooper, Lu Zhou, Chenyi Yang, Hediye Erdjument-Bromage, David Zagzag, Matija Snuderl, Marc Ladanyi, C Oliver Hanemann, Pengbo Zhou,[...]. Cancer Cell 2014
137
20

Mechanisms of chemoresistance in cancer stem cells.
Lissa Nurrul Abdullah, Edward Kai-Hua Chow. Clin Transl Med 2013
454
20

Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.
Lourdes Cortes-Dericks, Laurene Froment, Ruben Boesch, Ralph Alexander Schmid, Golnaz Karoubi. BMC Cancer 2014
55
20

BAP1 inhibits the ER stress gene regulatory network and modulates metabolic stress response.
Fangyan Dai, Hyemin Lee, Yilei Zhang, Li Zhuang, Hui Yao, Yuanxin Xi, Zhen-Dong Xiao, M James You, Wei Li, Xiaoping Su,[...]. Proc Natl Acad Sci U S A 2017
42
20

Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study.
Linda L Garland, Cathryn Rankin, David R Gandara, Saul E Rivkin, Katherine M Scott, Raymond B Nagle, Andres J P Klein-Szanto, Joseph R Testa, Deborah A Altomare, Ernest C Borden. J Clin Oncol 2007
160
20


BAP1 and cancer.
Michele Carbone, Haining Yang, Harvey I Pass, Thomas Krausz, Joseph R Testa, Giovanni Gaudino. Nat Rev Cancer 2013
347
20

Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma.
Kyoichi Kaira, Masakuni Serizawa, Yasuhiro Koh, Toshiaki Takahashi, Hirofumi Hanaoka, Noboru Oriuchi, Masahiro Endo, Haruhiko Kondo, Takashi Nakajima, Nobuyuki Yamamoto. Eur J Cancer 2012
33
20

BAP1 complex promotes transcription by opposing PRC1-mediated H2A ubiquitylation.
Antoine Campagne, Ming-Kang Lee, Dina Zielinski, Audrey Michaud, Stéphanie Le Corre, Florent Dingli, Hong Chen, Lara Z Shahidian, Ivaylo Vassilev, Nicolas Servant,[...]. Nat Commun 2019
37
20

Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma.
L Strizzi, A Catalano, G Vianale, S Orecchia, A Casalini, G Tassi, R Puntoni, L Mutti, A Procopio. J Pathol 2001
258
20

YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.
Shannon M White, Maria Laura Avantaggiati, Ivan Nemazanyy, Cristina Di Poto, Yang Yang, Mario Pende, Geoffrey T Gibney, Habtom W Ressom, Jeffery Field, Michael B Atkins,[...]. Dev Cell 2019
27
20

Oncolytic Viral Therapy for Mesothelioma.
Daniel F Pease, Robert A Kratzke. Front Oncol 2017
22
20

Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy.
Mir Alireza Hoda, Amir Mohamed, Bahil Ghanim, Martin Filipits, Balazs Hegedus, Masaya Tamura, Judit Berta, Bernd Kubista, Balazs Dome, Michael Grusch,[...]. J Thorac Oncol 2011
28
20

Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment.
X Sui, R Chen, Z Wang, Z Huang, N Kong, M Zhang, W Han, F Lou, J Yang, Q Zhang,[...]. Cell Death Dis 2013
683
20

Bortezomib sensitivity is tissue dependent and high expression of the 20S proteasome precludes good response in malignant pleural mesothelioma.
Robert Fred Henry Walter, Saskia Roxanne Sydow, Erika Berg, Jens Kollmeier, Daniel Christian Christoph, Sandra Christoph, Wilfried Ernst Erich Eberhardt, Thomas Mairinger, Jeremias Wohlschlaeger, Kurt Werner Schmid,[...]. Cancer Manag Res 2019
3
33

Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications.
Yuna Blum, Clément Meiller, Lisa Quetel, Nabila Elarouci, Mira Ayadi, Danisa Tashtanbaeva, Lucile Armenoult, François Montagne, Robin Tranchant, Annie Renier,[...]. Nat Commun 2019
45
20

Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma.
Robin Tranchant, Lisa Quetel, Anne Tallet, Clement Meiller, Annie Renier, Leanne de Koning, Aurelien de Reynies, Francoise Le Pimpec-Barthes, Jessica Zucman-Rossi, Marie-Claude Jaurand,[...]. Clin Cancer Res 2017
39
20

Systematic Analysis of Drug Vulnerabilities Conferred by Tumor Suppressor Loss.
Hongyu Ding, Jie Zhao, Yanli Zhang, Jiao Yu, Mingxian Liu, Xiaoxi Li, Liang Xu, Minghui Lin, Chuan Liu, Zhengjin He,[...]. Cell Rep 2019
14
20

Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status.
Marie Schoumacher, Stéphanie Le Corre, Alexandre Houy, Eskeatnaf Mulugeta, Marc-Henri Stern, Sergio Roman-Roman, Raphaël Margueron. Nat Med 2016
35
20

Loss of BAP1 function leads to EZH2-dependent transformation.
Lindsay M LaFave, Wendy Béguelin, Richard Koche, Matt Teater, Barbara Spitzer, Alan Chramiec, Efthymia Papalexi, Matthew D Keller, Todd Hricik, Katerina Konstantinoff,[...]. Nat Med 2015
183
20

Endoplasmic reticulum stress and cancer.
Raj Kumar Yadav, Soo-Wan Chae, Hyung-Ryong Kim, Han Jung Chae. J Cancer Prev 2014
172
20

Identification of potential therapeutic targets in malignant mesothelioma using cell-cycle gene expression analysis.
Solange Romagnoli, Ester Fasoli, Valentina Vaira, Monica Falleni, Caterina Pellegrini, Anna Catania, Massimo Roncalli, Antonio Marchetti, Luigi Santambrogio, Guido Coggi,[...]. Am J Pathol 2009
35
20


BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
Hiroyuki Nishikawa, Wenwen Wu, Ayaka Koike, Ryoko Kojima, Hiromichi Gomi, Mamoru Fukuda, Tomohiko Ohta. Cancer Res 2009
124
20

Heterogeneity in Malignant Pleural Mesothelioma.
Kathrin Oehl, Bart Vrugt, Isabelle Opitz, Mayura Meerang. Int J Mol Sci 2018
19
20

The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma.
L E Dalton, H J Clarke, J Knight, M H Lawson, J Wason, D A Lomas, W J Howat, R C Rintoul, D M Rassl, S J Marciniak. Br J Cancer 2013
40
20

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
F J Stott, S Bates, M C James, B B McConnell, M Starborg, S Brookes, I Palmero, K Ryan, E Hara, K H Vousden,[...]. EMBO J 1998
931
20

Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells.
Venkata Ramesh Dasari, Virginia Mazack, Wen Feng, John Nash, David J Carey, Radhika Gogoi. Oncotarget 2017
54
20

An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma.
A Linton, Y Y Cheng, K Griggs, Lyn Schedlich, M B Kirschner, S Gattani, S Srikaran, S Chuan-Hao Kao, B C McCaughan, S Klebe,[...]. Br J Cancer 2014
36
20

A Novel BRCA1-Associated Protein-1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1-Mediated DNA Repair.
Rossella Parrotta, Agata Okonska, Manuel Ronner, Walter Weder, Rolf Stahel, Lorenza Penengo, Emanuela Felley-Bosco. J Thorac Oncol 2017
30
20

Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed.
Pietro Bertino, Camillo Porta, Dario Barbone, Serena Germano, Sara Busacca, Sabrina Pinato, Giancarlo Tassi, Roberto Favoni, Giovanni Gaudino, Luciano Mutti. Thorax 2007
44
20

Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts.
Pietro Bertino, Federica Piccardi, Camillo Porta, Roberto Favoni, Michele Cilli, Luciano Mutti, Giovanni Gaudino. Clin Cancer Res 2008
58
20

BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines.
Delphine Merino, Gemma L Kelly, Guillaume Lessene, Andrew H Wei, Andrew W Roberts, Andreas Strasser. Cancer Cell 2018
125
20

Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets.
Oluf Dimitri Røe, Endre Anderssen, Helmut Sandeck, Tone Christensen, Erik Larsson, Steinar Lundgren. Lung Cancer 2010
46
20

Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells.
Krishna Kalyan Kolluri, Constantine Alifrangis, Neelam Kumar, Yuki Ishii, Stacey Price, Magali Michaut, Steven Williams, Syd Barthorpe, Howard Lightfoot, Sara Busacca,[...]. Elife 2018
13
20

Proteostasis control by the unfolded protein response.
Claudio Hetz, Eric Chevet, Scott A Oakes. Nat Cell Biol 2015
368
20

Targeting YAP in malignant pleural mesothelioma.
Wen-Qian Zhang, Yu-Yuan Dai, Ping-Chih Hsu, Hui Wang, Li Cheng, Yi-Lin Yang, Yu-Cheng Wang, Zhi-Dong Xu, Shu Liu, Geraldine Chan,[...]. J Cell Mol Med 2017
33
20

Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma.
Licun Wu, Walter Blum, Chang-Qi Zhu, Zhihong Yun, Laszlo Pecze, Mikihiro Kohno, Mei-Lin Chan, Yidan Zhao, Emanuela Felley-Bosco, Beat Schwaller,[...]. BMC Cancer 2018
8
20

Eaten alive: a history of macroautophagy.
Zhifen Yang, Daniel J Klionsky. Nat Cell Biol 2010
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.